The conference has now ended. To hear about our education events, please sign up to our mailing list

The Human Biome Conference

The Human Biome Conference has now ended. To hear about our education events, please sign up to our mailing list.


The Human Biome Conference brings together four researchers in different fields of host-microbiome research, together with Lecturer, Naturopath, Medical Herbalist and Psychotherapist, Debbie Cotton, ND.

We have been inspired by some incredible conferences in the UK and Europe, which showcased the latest research into microbiome-host interactions. After each one, we have been mind-blown and excited by the research and what it could mean for clinical practice, but there hasn't been anyone there in a clinical capacity to tie it all together. 

The Human Biome Conference has been designed to do just that. In one conference, we will showcase microbiome research before translating it into actionable, clinical practice tools. In the breaks, we will have research posters to browse, and laboratory tests and nutraceutical products - relevant to the learnings - to explore.


Speakers:

Prof Graham Rook

Prof Graham Rook | University College London

Our Microbial Partners and Why Our Immune System Needs Them
Dr Karen Koning

Dr Karen Koning | Winclove Probiotics 

Women & Their Microbes: The Vaginal & Urinary Microbiota

Dr David Moyes

Dr David Moyes | Kings College London 

Mycobiome-Host Interactions in Health & Disease
Dr Jaspal Patil

Dr Jaspal Patil | University of Gothenburg

The Oral Microbiome: LPS & Neurodegeneration

Learning Objectives:

Prof Graham Rook

  • How somatic mutation and receptor diversity enabled the co-evolution of a complex microbiota with our adaptive immune system
  • The required inputs of our adaptive immune system from our symbionts and our ecosystem - organisms, spores, genes, signals and epitope data - which is reflected in the health benefits of green space
  • Immuno-regulatory failure with diminished inputs, and the subsequent increase in prevalence of 'forbidden target' diseases (allergies, autoimmunity, IBD) and 'persistent inflammatory diseases' (CVD, metabolic syndrome and psychiatric conditions)
  • The influence of the gut- and environmental-microbiota on gut-brain and gut-immune-brain signalling and subsequent impacts on psychiatry

Dr Karen Koning

  • Overview of the role of microbes in female health and understand that:
    • female niches such as the breast, bladder, placenta, and amniotic fluid are not sterile as previously thought and that these microbes influence women’s health
    • the vaginal microbiota (VMB) is associated with the risk for UTI, and effects on the VMB associated with treatment of UTIs can affect the success of this therapy
    • the female urinary microbiota (FUM) is involved in a wide spectrum of poorly understood lower urinary tract disorders, including simple and recurrent UTI, overactive bladder syndrome and urgency urinary incontinence

Dr David Moyes

  • Overview of the multi-kingdom nature of the microbiome, including presence of fungi and viruses
  • Understanding the significance of the mycobiome (fungal community) in terms of host responses to fungi
  • Understanding the significance of specific fungal components in host-fungal interactions, particularly with reference to discrimination between commensal and pathogenic fungi
  • Understanding the impact of fungi on host homeostatic responses 
  • The clinical associations between mycobiome shifts and disease, and their functional basis

Dr Jaspal Patil

  • The molecular pathology of neurodegenerative diseases
  • Understanding the role of the oral microbiome
  • The oral microbiome and its connection with neuroinflammation and neurodegeneration
  • The oral microbiome and its connection with the gut-brain-axis

Debbie Cotton

Debbie Cotton | Clinical Educator Invivo
Translating Research into Clinical Practice

Learning Objectives:

  • Digest the key takeaways from the morning session
  • What does it mean to be an ecosystem, and how does this change our view of what human health is?
  • How can we foster a good relationship with our microbes for the sake of our immune system and our health?
  • What lab diagnostics can we use to help translate this research into clinical practice?
  • What therapeutics can we use to target imbalances of the oral, vaginal, gut, bladder micro/myco-biomes?


Refine